ArticleCancer medicine2026

Real-World Data of Second-Line Amrubicin Monotherapy in Patients With Extensive-Stage Small Cell Lung Cancer Who Received First-Line Chemoimmunotherapy or Chemotherapy: A Multicenter Retrospective Study.

Kei Sonehara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.